… compared the impact of three first-generation EGFR-TKIs on radical resected early-stage
NSCLC patients harboring EGFR mutations… adjuvant EGFR-TKIs had a better DFS compared to …

… CNS failure compared with gefitinib or erlotinib after adjusting for both EGFR mutation type
and … The second-generation EGFR TKI afatinib has a more potent inhibitory effect (ie, a lower …

… of NSCLC patients with EGFR mutations. There are limited reports on comparisons between
… The adverse effects of patients while on first-line EGFR-TKI and osimertinib are summarized …

… significant differences among adverse effects frequency … erlotinib is dominated by gefitinib
in our cost-effectiveness analysis. Accordingly, any further analysis will only compare gefitinib …

… in patients with advanced NSCLC harboring EGFR mutations compared to gefitinib use. …
analyze the distinct effects of the three TKIs and co-medications use in NSCLC patients with …

… compared with gefitinib in patients with EGFR mutation after … EGFR) tyrosine kinase inhibitors
(TKIs) gefitinib and erlotinib … -up and assess the impact of dacomitinib dose reduction on …

… EGFR TKIs developed for NSCLC were erlotinib and gefitinib… in the mechanisms of action
among the different generations. … with EGFR mutation-positive NSCLC, cross-trial comparisons …

… suggested that erlotinib 25 mg/d led to similar antitumor effect compared with … EGFR mutated
NSCLC, this study showed that erlotinib 100 mg/d had similar DCR compared with gefitinib …

… of efficacy of gefitinib plus olaparib, compared to gefitinib alone, as … effect would be expressed
as HR (gefitinib compared to … that ARID1A mutations co-existing with EGFR mutations and …

… TKIs including gefitinib and erlotinib, the second-generation … versus gefitinib alone in patients
with positive EGFR mutation, … by gefitinib enhances the antitumor effect in NSCLC cell lines …